Status:
COMPLETED
A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will assess the efficacy and safety of subcutaneous Mircera in the treatment of renal anemia in patients with chronic kidney disease who are not on dialysis and not receiving epoetin or any...
Eligibility Criteria
Inclusion
- adult patients \>=18 years of age;
- chronic kidney disease;
- anemia;
- not on dialysis therapy;
- not receiving epoetin.
Exclusion
- women who are pregnant, breastfeeding or using unreliable birth control methods;
- administration of another investigational drug within 4 weeks before screening, or during the study period.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
324 Patients enrolled
Trial Details
Trial ID
NCT00081471
Start Date
June 1 2004
End Date
July 1 2006
Last Update
November 2 2016
Active Locations (98)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles, California, United States, 90073
2
Mather, California, United States, 95655
3
Stanford, California, United States, 94305-5114
4
Stamford, Connecticut, United States, 06902